Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.

March 6, 1997

Medarex acquires Houston Biotechnology

March 5, 1997

Dorzolamide and timolol alone and in combination for glaucoma

March 4, 1997

AEterna codevelopment agreement for AE-941

Feb. 27, 1997

Bio-Technology General grants license to BioLon in Japan

Feb. 26, 1997

Comparative trial of dorzolamide and acetazolamide

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...